Share
Join Dr Karl Kruszelnicki, Lucy Smith and their scientific guests, with a bunch of curious triple j listeners for a weekly injection of science, myth-bashing and answers!
…
continue reading
Manage episode 488595769 series 2641323
Content provided by Australian Broadcasting Corporation and ABC listen. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Australian Broadcasting Corporation and ABC listen or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
There are concerns people are getting their hands on medicinal cannabis to treat conditions where there's very little evidence of benefit — and the possibility of harm.
Also, why weight loss drugs could improve treatment for people with schizophrenia. The full breadth of corporate ownership of radiology clinics is revealed.
And what questions need to be asked with IVF in the spotlight, as Monash IVF deals with the fallout from a second bungled embryo transfer.
References:
- Medicinal cannabis prescribing practices under scrutiny after scripts issued 'every 4 minutes' - ABC News
- ‘Infuriating and dangerous’: Psychiatrist tries and fails to speak with his patients’ medicinal cannabis prescribers - AusDoc.
- Efficacy and safety of semaglutide versus placebo for people with schizophrenia on clozapine with obesity (COaST): a phase 2, multi-centre, participant and investigator- blinded, randomised controlled trial in Australia
- Corporatisation and ownership concentration in diagnostic imaging: an audit of Australian practices
262 episodes
))
